Starvation-induced Wernicke's encephalopathy in schizophrenia
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-06-01
著者
-
Yang Yen
Department Of Psychiatry National Cheng Kung University Medical Center
-
Yeh Tzung
Department Of Psychiatry National Cheng Kung University Medical Center
-
Chen Po
Department Of Psychiatry National Cheng Kung University Medical Center
-
TSAI HSIANG-YI
Department of Psychiatry, College of Medicine, National Cheng Kung University and Hospital, Taiwan
-
WANG SHEEI-MEEI
Department of Psychiatry, College of Medicine, National Cheng Kung University and Hospital, Taiwan
-
Tsai Hsiang-yi
Department Of Psychiatry College Of Medicine National Cheng Kung University And Hospital Taiwan
-
Wang Sheei-meei
Department Of Psychiatry College Of Medicine National Cheng Kung University And Hospital Taiwan
-
Yang Yen
Department Of Psychiatry College Of Medicine National Cheng Kung University
-
Chen Po
Department Of Psychiatry College Of Medicine National Cheng Kung University
-
Chen Po
Department Of Earth Sciences University Of Southern California
関連論文
- Seismic velocity variations on the San Andreas fault caused by the 2004 M6 Parkfield Earthquake and their implications
- The relationship among insight, cognitive function of patients with schizophrenia and their relatives' perception
- The psychological well-being and associated factors of caregivers of outpatients with schizophrenia in Taiwan
- Starvation-induced Wernicke's encephalopathy in schizophrenia
- Correlation between scores on Continuous Performance Test and plasma concentration for schizophrenic patients on risperidone
- Correlation between performance on the Continuous Performance Test and economic costs in patients with schizophrenia
- Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy
- Pharmacoeconomic evaluation of schizophrenia in Taiwan : Model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs
- Olanzapine in Chinese treatment-resistant patients with schizophrenia : An open-label, prospective trial